Filing Details
- Accession Number:
- 0001209191-15-046804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-26 17:31:00
- Reporting Period:
- 2015-05-21
- Filing Date:
- 2015-05-26
- Accepted Time:
- 2015-05-26 17:31:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324991 | L James Tyree | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-22 | 27,027 | $0.00 | 27,027 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-05-22 | 12,703 | $7.45 | 14,324 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2015-05-21 | 11,795 | $0.00 | 11,795 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2015-05-22 | 27,027 | $0.00 | 27,027 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 11,795 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Shares were acquired upon vesting of restricted stock units awarded on May 22, 2014.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover estimated taxes due upon vesting of restricted stock units.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.30 to $7.6052 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
- 100% of the restricted stock units will vest on May 21, 2016, subject to the Reporting Person's continued service to the Company on such date. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
- 100% of the restricted stock units vested on May 22, 2015. Vested shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.
Billionaire Hedge Funds
